Biotech giant Amgen plans to open to technology & innovation centre in Hyderabad
biotech giant Amgen on Friday announced its plans to open a new technology and innovation site in Hyderabad, India.
The site, to be known as Amgen, will be located in HITEC City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower, with a potential to accommodate up to 3,000 people. The site will be operational in Q4 2024.
Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise.
The site will offer roles that strengthen key areas of Amgen’s business, including artificial intelligence (AI), data science, life science and other additional global capabilities over time.
Som Chattopadhyay has been appointed as national executive to lead Amgen’s expanded presence in India.
The California based Amgen with revenues of $28.2 billion in 2023, is one of the world's leading biotech companies with nearly 27,000 employees and has a presence in around 100 countries and regions worldwide, including India.
«At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency — an incredibly exciting milestone for which we have been preparing for over a decade,” said David M. Reese, executive vice president and chief technology officer at Amgen.
»Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class
